Gary Hennerberg
Directeur/Bestuurslid bij FINDIT
Vermogen: 739 625 $ op 30-04-2024
Actieve functies van Gary Hennerberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FINDIT | Directeur/Bestuurslid | 08-03-2024 | - |
Bedrijfssecretaris | 08-03-2024 | - |
Loopbaan van Gary Hennerberg
Eerdere bekende functies van Gary Hennerberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Directeur/Bestuurslid | 01-05-2016 | - |
Verkoop & Marketing | 01-05-2016 | - |
Opleiding van Gary Hennerberg
Fort Hays State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Director/Board Member | 2 |
Sales & Marketing | 1 |
Corporate Secretary | 1 |
Sectoraal
Consumer Services | 2 |
Technology Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
FINDIT | Technology Services |
Bedrijven in privébezit | 1 |
---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
- Beurs
- Insiders
- Gary Hennerberg
- Ervaring